Main Article Content


Ongoing research into cancer cures and therapeutic agents is being carried out by scientists worldwide to alleviate the rising burden of this insurmountable illness. Research on lumichrome, a photoproduct of the vitamin riboflavin, led us to discover that it has anticancer properties against lung cancer. More research is needed to determine how effective it is. An anticancer ability of lumichrome and its synthetic derivatives against liver, breast, and colorectal cancer was shown in this work. Cytotoxic activity against Hep3B (liver carcinoma), SkBr3 (Breast adenocarcinoma), and BRAF (Colorectal cancer) cell lines was evaluated using the MTT assay, which is a cytotoxicity test. These results ranged from 8.9 to 23.9 micrograms per milliliter. The IC50 for lumichrome and its synthetic derivative was 8.9 and 16.6 µg/ml, respectively, for Hep3B cells. Activation of apoptosis and interference with transcription is assumed to be the primary mechanisms of action of these substances. The mechanism of action of these products will need to be studied in the future.


lumichrome anticancer agent breast cancer liver carcinoma colon cancer

Article Details

How to Cite
Robledo, D. A. R., & Muhammad, G. (2021). Evaluation of Cytotoxic Properties of Lumichrome-derived compounds on Breast Adenocarcinoma (SkBr3), Colorectal Cancer (BRAF), and Liver Carcinoma (Hep3B). CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES, 2(6), 55-59.


  1. 1. Zhai XF, Chen Z, Li B, Shen F, Fan J, Zhou WP, Yang YK, Xu J, Qin X, Li LQ, Ling CQ. Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial. J Integr Med. 2013;11(2):90–100.
  2. 2. Cragg GM, Newman DJ. Plants as a source of anticancer agents. J Ethnopharmacology. 2005;100(1-2):72–9.
  3. 3. Chantarawong W, Kuncharoen N, Tanasupawat S, Chanvorachote P. Lumichrome Inhibits Human Lung Cancer Cell Growth and Induces Apoptosis via a p53-Dependent Mechanism. Nutr Cancer. 2019;71(8):1390-1402. DOI: 10.1080/01635581.2019.1610183. Epub 2019 May 10. PMID: 31074646.
  4. 4. Phi LTH, Sari IN, Yang Y-G, Lee S-H, Jun N, et al.: Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int 2018, 1, 2018.
  5. 5. Yi Yuan, Yongyun Zhao, Lianqi Chen, Jiasi Wu, Gangyi Chen, Sheng Li, Jiawei Zou, Rong Chen, Jian Wang, Fan Jiang, Zhuo Tang, Selective tumor cell death induced by irradiated riboflavin through recognizing DNA G–T mismatch, Nucleic Acids Research, Volume 45, Issue 15, 6 September 2017, Pages 8676–8683,
  6. 6. Ströch K, Zeeck A, Antal N, Fiedler HP. (2005) Retymicin, gentamycin B, saquayamycin Z, and ribofuranosyllumichrome, novel secondary metabolites from Micromonospora sp. Tü 6368. II. Structure elucidation. The Journal of Antibiotics, 58, 103–110.
  7. 7. Dakora FD, Matiru VN, Kanu AS. (2015) Rhizosphere ecology of lumichrome and riboflavin, two bacterial signal molecules eliciting developmental changes in plants. Frontiers in Plant Science, 6, 700.
  8. 8. Yamamoto K, Asano Y. (2015) Efficient production of lumichrome by Microbacterium sp. strain TPU 3598. Applied and Environmental Microbiology, 91, 7360–7367.
  9. 9. Phillips DA, Joseph CM, Yang GP, Martinez-Romero E, Sanborn JR, Volpin H. (1999) Identification of lumichrome as a Sinorhizobium enhancer of alfalfa root respiration shoot growth. Proceedings of the National Academy of Sciences, 96, 12275–12280.
  10. 10. Tsukamoto S, Kato H, Hirota H, Fusetani N. (1999) Lumichrome. A larval metamorphosis-inducing substance in the ascidian Hhalocynthia roretzi. European Journal of Biochemistry, 264, 785-789.